![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells. PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
Enrollment on track in Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 60% of sites...
PRINCETON, N.J., May 30, 2024 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule...
Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop Foundation Medicine’s tissue-based comprehensive genomic profiling...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -1.93548387097 | 1.55 | 1.63 | 1.49 | 108817 | 1.52457851 | CS |
4 | 0.02 | 1.33333333333 | 1.5 | 1.66 | 1.43 | 238658 | 1.56125348 | CS |
12 | -0.13 | -7.87878787879 | 1.65 | 1.75 | 1.4 | 252863 | 1.57878236 | CS |
26 | -0.18 | -10.5882352941 | 1.7 | 2.26 | 1.4 | 407233 | 1.73294489 | CS |
52 | -4.54 | -74.9174917492 | 6.06 | 6.98 | 1.175 | 533427 | 2.2360718 | CS |
156 | -27.93 | -94.8387096774 | 29.45 | 31.31 | 1.175 | 645504 | 10.27258592 | CS |
260 | -33.53 | -95.6633380884 | 35.05 | 63.22 | 1.175 | 549742 | 13.05506722 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions